Vivos Therapeutics, Inc. | Business Contracts

Placement Agency Agreement, dated January 5, 2023, between the Company and the Placement Agents (Filed With SEC on January 9, 2023)

Form of Registration Rights Agreement, dated January 5, 2023, between the Company and the Purchaser (Filed With SEC on January 9, 2023)

Form of Securities Purchase Agreement, dated January 5, 2023, between the Company and the Purchaser (Filed With SEC on January 9, 2023)

Form of Pre-Funded Warrant (Filed With SEC on January 9, 2023)

Form of Common Stock Warrant (Filed With SEC on January 9, 2023)

Sabbatical Agreement dated September 22, 2021, by and between Vivos Therapeutics, Inc. and Dr. G. Dave Singh (Filed With SEC on September 27, 2021)

Representatives Warrant, dated May 11, 2021 (Filed With SEC on May 12, 2021)

Underwriting Agreement, dated May 6, 2021, by and between the Company and Roth, as representative of the several underwriters (Filed With SEC on May 12, 2021)

Form of Representatives Warrant (Filed With SEC on May 3, 2021)

Form of Underwriting Agreement (Filed With SEC on May 3, 2021)

Licensing, Distribution, and Marketing Agreement dated February 12, 2021 between the Company and MyCardio, LLC (Filed With SEC on March 25, 2021)

Description of Registered Securities (Filed With SEC on March 25, 2021)

Underwriting Agreement, dated December 10, 2020, by and between the Company and Roth, as representative of the several underwriters (Filed With SEC on December 15, 2020)

Form of Representatives Warrant, dated December 15, 2020 (Filed With SEC on December 15, 2020)

Form of Representatives Warrant (Filed With SEC on November 19, 2020)

Form of Underwriting Agreement (Filed With SEC on November 19, 2020)

Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc (Filed With SEC on October 26, 2020)

Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc (Filed With SEC on October 26, 2020)

Form of Stock Certificate (Filed With SEC on October 9, 2020)

Vivos Therapeutics, Inc. 2019 Stock Option and Stock Issuance Plan (Filed With SEC on October 9, 2020)

Amended and Restated Executive Employment Agreement, dated October 8, 2020, between Bradford Amman and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)

Amended and Restated Executive Employment Agreement, dated October 9, 2020, between G. Dave Singh and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)

Amended and Restated Executive Employment Agreement, dated October 8, 2020, between R. Kirk Huntsman and Vivos Therapeutics, Inc (Filed With SEC on October 9, 2020)

Security Agreement, dated May 6, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh (Filed With SEC on October 9, 2020)

Intellectual Property & Asset Purchase Agreement, dated May 4, 2017, by and between Vivos Biotechnologies, Inc. and Dr. Gurdev Dave Singh (Filed With SEC on October 9, 2020)

Amendment to Share Exchange Agreement, dated September 15, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First... (Filed With SEC on October 9, 2020)

Share Exchange Agreement, dated August 16, 2016, among Vivos Therapeutics, Inc., BioModeling Solutions, Inc., shareholders of BioModeling Solutions, Inc., First Vivos, Inc., and... (Filed With SEC on October 9, 2020)

Vivos Therapeutics, Inc. 2017 Stock Option and Stock Issuance Plan (Filed With SEC on October 9, 2020)

Vivos Therapeutics, Inc. (28)